プロモーションスケジュール IMV Inc.
詳細なスケジュール
簡易グラフ
会社について IMV Inc.
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. さらに詳しく| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.imv-inc.com |
| Цена ао | 0.0001 |
| 1日あたりの価格変動: | 0% (0.0001) |
|---|---|
| 週ごとの価格変動: | 0% (0.0001) |
| 月ごとの料金変更: | 0% (0.0001) |
| 3ヶ月間の価格変動: | 0% (0.0001) |
| 半年間の価格変動: | 0% (0.0001) |
| 年間の価格変動: | 0% (0.0001) |
| 3年間の価格推移: | -100% (15) |
| 5年間の価格推移: | -100% (21.8) |
| 年初からの価格変動: | 0% (0.0001) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Andrew Hall M.Sc. | CEO & Director | 680.6k | |
| Ms. Brittany Davison C.A., CPA | Chief Accounting Officer, Corporate Secretary & Director | 207.9k | 1990 (35 年) |
| Delphine Davan | Senior Director of Communications & Investor Relations | N/A | |
| Mr. Stephan Fiset M.B.A., M.Sc. | Vice President of Clinical Research | N/A | |
| Dr. Jeremy R. Graff Ph.D. | Chief Scientific Officer | 1971 (54 年) |
住所: Canada, Dartmouth. NS BB C, 130 Eileen Stubbs Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.imv-inc.com
Webサイト: https://www.imv-inc.com
